Abyntek Biopharma
Private Company
Total funding raised: $15M
Overview
Abyntek Biopharma operates as a key supplier in the life sciences research tools market, focusing on the production of antibodies, proteins, and diagnostic kits. While not a traditional drug development biotech, it plays a crucial supporting role in biomedical research by providing essential reagents. The company's strategic direction involves expanding its product portfolio and potentially moving into more advanced diagnostic or therapeutic areas. Its position in the Spanish and European biotech supply chain is well-established.
Technology Platform
Platform for custom antibody development, recombinant protein production, and immunoassay kit development, leveraging hybridoma technology and protein expression systems.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes against large multinationals like Abcam (Danaher) and Thermo Fisher, as well as numerous niche providers. Differentiation is achieved through specialized custom services, agility, deep expertise in specific targets, and strong regional customer relationships in Spain and Europe.